SCHEMBL3025865

SCHEMBL3025865

CC(=O)c1ccc(C=Cc2cccc(O)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.57
▸ HDAC1 Q13547 1/20 0.57
▸ HDAC6 Q9UBN7 1/20 0.57
▸ LCK P06239 2/20 0.56
▸ TTR P02766 1/20 0.54
▸ CCNB2 O95067 1/20 0.51
▸ CDK1 P06493 1/20 0.51
▸ CDK4 P11802 1/20 0.51
▸ CCNB1 P14635 1/20 0.51
▸ CCND1 P24385 1/20 0.51
▸ CCNB3 Q8WWL7 1/20 0.51
▸ ABL1 P00519 1/20 0.51
▸ BCR P11274 1/20 0.51
▸ KMT2A Q03164 1/20 0.50
▸ P4HB P07237 1/20 0.48
▸ PTPN1 P18031 1/20 0.47
▸ FBP1 P09467 1/20 0.47
▸ NR1H4 Q96RI1 1/20 0.47
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10807599 0.84 TTR (0.70) KDM1AHDAC1HDAC6LCKTTR
SCHEMBL10807601 0.84 TTR (0.70) KDM1AHDAC1HDAC6LCKTTR
SCHEMBL18860733 0.84 PTGS1 (0.61) KDM1AHDAC6LCKTTRABL1
SCHEMBL18860735 0.84 PTGS1 (0.61) KDM1AHDAC6LCKTTRABL1
SCHEMBL700150 0.81 KMT2A (0.64) HDAC1HDAC6KMT2AMAOB
SCHEMBL700149 0.81 KMT2A (0.64) HDAC1HDAC6KMT2AMAOB
SCHEMBL8589167 0.81 LMNA (0.53) KDM1AHDAC1HDAC6KMT2AMAOB
SCHEMBL8589165 0.81 LMNA (0.53) KDM1AHDAC1HDAC6KMT2AMAOB
SCHEMBL7423544 0.80 CYP3A4 (0.66) KDM1AHDAC1HDAC6LCKTTR
(E)-3,4'-Stilbendiol SCHEMBL720092 0.79 LCK (0.72) KDM1AHDAC6LCKTTRCCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912234-B2 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol UNIAO Brasileria de Educacao e Assistencia—Mantenedora da PUCRS (BR) 2014-12-16 — — US claimed
US-20130040920-A1 COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL UNIAO Brasileira de Educacao e Assistencia- Matenedora da PUCRS (BR) 2013-02-14 — — US claimed
US-20100204179-A1 Resveratrol complex and process for the preperation UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA - MANTENEDORA DA PUCRS (BR) 2010-08-12 — — US claimed
EP-2178525-A1 RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION União Brasileira De Educação E Assistência - Mantenedora Da Pucrs (BR) 2010-04-28 — — EP claimed
WO-2009012551-A1 RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION UNIÄO BRASILEIRA DE EDUCAÇAO E ASSITENCIA-MANTENEDORA DA PUCRS (BR) 2009-01-29 — — WO claimed
US-20230061229-A1 SMART WOUND DRESSINGS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2023-03-02 — — US disclosed
WO-2021137242-A1 SMART WOUND DRESSINGS INTELIGELS LTD. (IL) 2021-07-08 — — WO disclosed
US-8912234-B2 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol UNIAO Brasileria de Educacao e Assistencia—Mantenedora da PUCRS (BR) 2014-12-16 — — US disclosed
US-8476248-B2 Process for the preparation of a water-soluble complex having resveratrol compounds; products comprising said complex; and uses thereof Uniao Brasileira de Educacao e Assistencia—Mantenedora da PUCRS (BR) 2013-07-02 — — US disclosed
US-20130040920-A1 COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL UNIAO Brasileira de Educacao e Assistencia- Matenedora da PUCRS (BR) 2013-02-14 — — US disclosed
US-20100204179-A1 Resveratrol complex and process for the preperation UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA - MANTENEDORA DA PUCRS (BR) 2010-08-12 — — US disclosed
EP-2178525-A1 RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION União Brasileira De Educação E Assistência - Mantenedora Da Pucrs (BR) 2010-04-28 — — EP disclosed
WO-2009012551-A1 RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION UNIÄO BRASILEIRA DE EDUCAÇAO E ASSITENCIA-MANTENEDORA DA PUCRS (BR) 2009-01-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040920-A1 COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL GPR119, MAVS, SIRT1 KDM1A 3218/4885HDAC1 979/4885HDAC6 1649/4885
US-20100204179-A1 Resveratrol complex and process for the preperation SI, GPR119, GYS1 KDM1A 4512/4885HDAC1 498/4885HDAC6 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback